Results 81 to 90 of about 6,634 (171)

Metformin Hydrochloride Loaded Mucoadhesive Microspheres and Nanoparticles for Anti-Hyperglycemic and Anticancer Effects Using Factorial Experimental Design. [PDF]

Drug Des Devel Ther, 2023
Kotha AA, Ahmad SU, Dewan I, Bhuiyan MA, Rahman FI, Naina Mohamed I, Reza MS.   +6 more
europepmc   +1 more source

Effects of food on pharmacokinetics and safety of metformin hydrochloride tablets: A meta-analysis of pharmacokinetic, bioavailability, or bioequivalence studies. [PDF]

Heliyon, 2023
Sun ML, Liu F, Yan P, Chen W, Wang XH.
europepmc   +1 more source

Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride. [PDF]

Int J Endocrinol, 2022
Chen Z, Zige L, Sai Kiang Y, Desheng C.
europepmc   +1 more source

Evaluation of Metformin Hydrochloride Tailoring Bilosomes as an Effective Transdermal Nanocarrier. [PDF]

Int J Nanomedicine, 2022
Salem HF, Nafady MM, Ali AA, Khalil NM, Elsisi AA.   +4 more
europepmc   +1 more source

Metformin hydrochloride entrapment in sorbitan monostearate for intestinal permeability enhancement and pharmacodynamics. [PDF]

Sci Rep, 2021
Mady OY, Al-Shoubki AA, Donia AA, Qasim W.   +3 more
europepmc   +1 more source

Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Metformin Hydrochloride in Tablet Dosage Forms by HPLC. [PDF]

Pharmaceutics, 2022
Sha'at M, Spac AF, Stoleriu I, Bujor A, Cretan MS, Hartan M, Ochiuz L.   +6 more
europepmc   +1 more source

In vitro-in vivo availability of metformin hydrochloride-PLGA nanoparticles in diabetic rats in a periodontal disease experimental model. [PDF]

Pharm Biol, 2021
Pereira ASBF, de Souza Lima ML, da Silva-Junior AA, Dos Santos Silva E, de Araújo Júnior RF, Martins AA, Alves JSF, Oliveira AS, De Santis Ferreira L, de Araújo Costa ECT, Guerra GCB, de Medeiros CACX, Brito GAC, de Carvalho Leitao RF, de Araújo AA.   +14 more
europepmc   +1 more source

Formulation And Evaluation Of Floating Microspheres Of Metformin Hydrochloride

, 2017
Metformin hydrochloride is a hypoglycemic agent used for the treatment of non-insulin dependent Diabetes mellitus. It is a BCS class III drug having high solubility and poor permeability. Plasma half life ranges from 1.5 to 3 hours and oral bioavailability is 50 to 60 %. Hence require frequent oral administration for adequate treatment of Diabetes.
openaire   +2 more sources

<i>In vitro</i> Bioequivalence Analysis of Generic Metformin Hydrochloride Film-coated Tablets. [PDF]

Acta Med Philipp
Buenavidez ZP, Brum AKP, Manzo KMT, Mora ZLM, Crucis PM, Lapuz AMR, Miranda KJA, Carandang RRZ.   +7 more
europepmc   +1 more source

Determination and Correlation of Solubility of Metformin Hydrochloride in Aqueous Binary Solvents from 283.15 to 323.15 K. [PDF]

ACS Omega, 2022
Yu C, Sun X, Wang Y, Du S, Shu L, Sun Q, Xue F.   +6 more
europepmc   +1 more source